Report Detail
Global (United States, European Union and China) Influenza Vaccination Market Research Report 2019-2025
- RnM3669402 |
- 14 August, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Influenza (flu) is a contagious respiratory disease caused by influenza viruses that infect the respiratory tract (nose, throat, and lungs) in humans. The symptoms and complications of flu are more severe than common cold. The symptoms associated with influenza may include fever, headache, malaise, cough, sore throat, nasal congestion, and body aches. Influenza vaccine can prevent illness and death caused
Stringent regulatory framework along with the low accessibility of the product in the developing countries may restrain the market growth.
In 2019, the market size of Influenza Vaccination is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Influenza Vaccination.
This report studies the global market size of Influenza Vaccination, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Influenza Vaccination sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Abbott (U.S.)
AstraZeneca (Europe)
BioCryst Pharmaceuticals, Inc. (U.S.)
Novartis AG (Europe)
DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific)
GlaxoSmithKline plc. (Europe)
Hualan Biological Engineering Inc (Asia Pacific)
Mitsubishi Tanabe Pharma Corporation (Asia Pacific)
F. Hoffmann-La Roche Ltd (Europe)
Sanofi (Europe)
Market Segment by Product Type
Egg Based
Cell Culture
Recombinant
Market Segment by Application
Hospitals
Research Organizations
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Influenza Vaccination status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Influenza Vaccination manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Influenza Vaccination are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Influenza Vaccination Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Egg Based
- 1.3.3 Cell Culture
- 1.3.4 Recombinant
- 1.4 Market Segment by Application
- 1.4.1 Global Influenza Vaccination Market Share by Application (2019-2025)
- 1.4.2 Hospitals
- 1.4.3 Research Organizations
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Influenza Vaccination Market Size
- 2.1.1 Global Influenza Vaccination Revenue 2014-2025
- 2.1.2 Global Influenza Vaccination Sales 2014-2025
- 2.2 Influenza Vaccination Growth Rate by Regions
- 2.2.1 Global Influenza Vaccination Sales by Regions 2014-2019
- 2.2.2 Global Influenza Vaccination Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Influenza Vaccination Sales by Manufacturers
- 3.1.1 Influenza Vaccination Sales by Manufacturers 2014-2019
- 3.1.2 Influenza Vaccination Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Influenza Vaccination Revenue by Manufacturers (2014-2019)
- 3.2.2 Influenza Vaccination Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Influenza Vaccination Market Concentration Ratio (CR5 and HHI)
- 3.3 Influenza Vaccination Price by Manufacturers
- 3.4 Key Manufacturers Influenza Vaccination Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Influenza Vaccination Market
- 3.6 Key Manufacturers Influenza Vaccination Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Egg Based Sales and Revenue (2014-2019)
- 4.1.2 Cell Culture Sales and Revenue (2014-2019)
- 4.1.3 Recombinant Sales and Revenue (2014-2019)
- 4.2 Global Influenza Vaccination Sales Market Share by Type
- 4.3 Global Influenza Vaccination Revenue Market Share by Type
- 4.4 Influenza Vaccination Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Influenza Vaccination Sales by Application
6 United States
- 6.1 United States Influenza Vaccination Breakdown Data by Company
- 6.2 United States Influenza Vaccination Breakdown Data by Type
- 6.3 United States Influenza Vaccination Breakdown Data by Application
7 European Union
- 7.1 European Union Influenza Vaccination Breakdown Data by Company
- 7.2 European Union Influenza Vaccination Breakdown Data by Type
- 7.3 European Union Influenza Vaccination Breakdown Data by Application
8 China
- 8.1 China Influenza Vaccination Breakdown Data by Company
- 8.2 China Influenza Vaccination Breakdown Data by Type
- 8.3 China Influenza Vaccination Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Influenza Vaccination Breakdown Data by Company
- 9.2 Rest of World Influenza Vaccination Breakdown Data by Type
- 9.3 Rest of World Influenza Vaccination Breakdown Data by Application
- 9.4 Rest of World Influenza Vaccination Breakdown Data by Countries
- 9.4.1 Rest of World Influenza Vaccination Sales by Countries
- 9.4.2 Rest of World Influenza Vaccination Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Abbott (U.S.)
- 10.1.1 Abbott (U.S.) Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Influenza Vaccination
- 10.1.4 Influenza Vaccination Product Introduction
- 10.1.5 Abbott (U.S.) Recent Development
- 10.2 AstraZeneca (Europe)
- 10.2.1 AstraZeneca (Europe) Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Influenza Vaccination
- 10.2.4 Influenza Vaccination Product Introduction
- 10.2.5 AstraZeneca (Europe) Recent Development
- 10.3 BioCryst Pharmaceuticals, Inc. (U.S.)
- 10.3.1 BioCryst Pharmaceuticals, Inc. (U.S.) Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Influenza Vaccination
- 10.3.4 Influenza Vaccination Product Introduction
- 10.3.5 BioCryst Pharmaceuticals, Inc. (U.S.) Recent Development
- 10.4 Novartis AG (Europe)
- 10.4.1 Novartis AG (Europe) Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Influenza Vaccination
- 10.4.4 Influenza Vaccination Product Introduction
- 10.4.5 Novartis AG (Europe) Recent Development
- 10.5 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific)
- 10.5.1 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Influenza Vaccination
- 10.5.4 Influenza Vaccination Product Introduction
- 10.5.5 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Recent Development
- 10.6 GlaxoSmithKline plc. (Europe)
- 10.6.1 GlaxoSmithKline plc. (Europe) Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Influenza Vaccination
- 10.6.4 Influenza Vaccination Product Introduction
- 10.6.5 GlaxoSmithKline plc. (Europe) Recent Development
- 10.7 Hualan Biological Engineering Inc (Asia Pacific)
- 10.7.1 Hualan Biological Engineering Inc (Asia Pacific) Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Influenza Vaccination
- 10.7.4 Influenza Vaccination Product Introduction
- 10.7.5 Hualan Biological Engineering Inc (Asia Pacific) Recent Development
- 10.8 Mitsubishi Tanabe Pharma Corporation (Asia Pacific)
- 10.8.1 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Influenza Vaccination
- 10.8.4 Influenza Vaccination Product Introduction
- 10.8.5 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Recent Development
- 10.9 F. Hoffmann-La Roche Ltd (Europe)
- 10.9.1 F. Hoffmann-La Roche Ltd (Europe) Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Influenza Vaccination
- 10.9.4 Influenza Vaccination Product Introduction
- 10.9.5 F. Hoffmann-La Roche Ltd (Europe) Recent Development
- 10.10 Sanofi (Europe)
- 10.10.1 Sanofi (Europe) Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Influenza Vaccination
- 10.10.4 Influenza Vaccination Product Introduction
- 10.10.5 Sanofi (Europe) Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Influenza Vaccination Sales Channels
- 11.2.2 Influenza Vaccination Distributors
- 11.3 Influenza Vaccination Customers
12 Market Forecast
- 12.1 Global Influenza Vaccination Sales and Revenue Forecast 2019-2025
- 12.2 Global Influenza Vaccination Sales Forecast by Type
- 12.3 Global Influenza Vaccination Sales Forecast by Application
- 12.4 Influenza Vaccination Forecast by Regions
- 12.4.1 Global Influenza Vaccination Sales Forecast by Regions 2019-2025
- 12.4.2 Global Influenza Vaccination Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Influenza Vaccination. Industry analysis & Market Report on Influenza Vaccination is a syndicated market report, published as Global (United States, European Union and China) Influenza Vaccination Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Influenza Vaccination market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
